Buckingham Capital Management (Ohio)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-6,682
Closed -$393K 114
2020
Q2
$393K Sell
6,682
-7,459
-53% -$446K 0.09% 102
2020
Q1
$788K Sell
14,141
-2,100
-13% -$128K 0.2% 77
2019
Q4
$1.04M Buy
+16,241
New +$930K 0.18% 89
2014
Q2
Sell
-12,736
Closed -$662K 175
2014
Q1
$662K Sell
12,736
-6,824
-35% -$363K 0.22% 116
2013
Q4
$1.04M Sell
19,560
-1,015
-5% -$51.7K 0.36% 85
2013
Q3
$951K Sell
20,575
-1,530
-7% -$67.2K 0.39% 86
2013
Q2
$988K Buy
+22,105
New +$960K 0.4% 76

Other funds holding BMY

Buckingham Capital Management (Ohio)'s BMY Position: Q3 2020 in Review

Buckingham Capital Management (Ohio) sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 6,682 shares — an estimated $393K sold.

Buckingham Capital Management (Ohio) first reported a position in BMY in Q2 2013 and held it in 7 quarters. The position peaked at $1.04M in Q4 2019. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • Buckingham Capital Management (Ohio) reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
  • Buckingham Capital Management (Ohio) sold 6,682 Bristol-Myers Squibb shares in Q3 2020, an estimated $393K.
  • Buckingham Capital Management (Ohio) first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 7 quarters.
  • Buckingham Capital Management (Ohio)'s Bristol-Myers Squibb position peaked at $1.04M in Q4 2019.
  • 2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Buckingham Capital Management (Ohio)'s 13F filing for Q3 2020, filed 2 Nov 2020.